Literature DB >> 15638892

Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time.

Simon R J Bott1, A Alex Freeman, Sally Stenning, Jonathan Cohen, M Constance Parkinson.   

Abstract

OBJECTIVE: To examine the preoperative features and pathological outcomes of clinical significance of 1001 consecutive essentially unscreened men who had a radical prostatectomy (RP) in the UK between 1988 and 2002, and their changes over time. PATIENTS AND METHODS: The details of men whose RP specimen was submitted for analysis were entered into the RP database held at the University College Hospital, London; the National Health Service and private patients of 17 surgeons were included. The age, mode of diagnosis, preoperative prostate specific antigen (PSA) level, biopsy and RP findings were compared over time.
RESULTS: The mean (range) age of the men was 62 (40-76) years, the median PSA 8 (0.1-146) ng/mL and the median biopsy Gleason sum score 6; these preoperative features did not change over the study period. The diagnosis of prostate cancer was made by transurethral resection of the prostate alone in 48 men (5%). The maximum number of patients receiving neoadjuvant androgen ablation was 21 (33%) in 1996, and subsequently declined. The median (range) RP Gleason sum score was 7 (4-9). The biopsy Gleason score correlated with the prostatectomy Gleason score in 252 (47%) of 536 men, being lower in 170 (32%) and higher in 113 (21%). The median tumour volume was 2 mL (focus of invasive acini - 31 mL) and the incidence of positive intra- and extraprostatic margins was 52%. Both tumour volume and extraprostatic margin positivity declined with time.
CONCLUSIONS: The preoperative features and pathological findings from this UK series are similar to those of other reported cohorts from unscreened populations. The incidence of positive extraprostatic surgical margins, tumour volume and stage decreased with time.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15638892     DOI: 10.1111/j.1464-410X.2005.05245.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  11 in total

Review 1.  Open versus laparoscopic radical prostatectomy. The case for open radical prostatectomy.

Authors:  Nadeem Shaida; Peter R Malone
Journal:  Ann R Coll Surg Engl       Date:  2007-03       Impact factor: 1.891

2.  Addressing the needs of the high-risk prostate cancer patient.

Authors:  Leonard G Gomella
Journal:  Rev Urol       Date:  2005

3.  Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous survey.

Authors:  Georgios Lyratzopoulos; Josephine M Barbiere; David C Greenberg; Karen A Wright; David E Neal
Journal:  BMJ       Date:  2010-04-21

4.  Complications and functional results of surgery for locally advanced prostate cancer.

Authors:  S G Joniau; A A Van Baelen; C Y Hsu; H P Van Poppel
Journal:  Adv Urol       Date:  2012-01-12

5.  Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study.

Authors:  Myong Kim; Cheryn Song; In Gab Jeong; Seung-Kwon Choi; Myungchan Park; Myungsun Shim; Young Seok Kim; Dalsan You; Jun Hyuk Hong; Choung-Soo Kim; Hanjong Ahn
Journal:  BMC Cancer       Date:  2018-03-09       Impact factor: 4.430

Review 6.  The correlation between the gleason score of the biopsy and that of the prostatectomy patch.

Authors:  W Bai; Y Fadil; O Idrissi; M Dakir; A Debbagh; R Abouteib
Journal:  Ann Med Surg (Lond)       Date:  2021-02-26

7.  Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study.

Authors:  D M Berney; A Gopalan; S Kudahetti; G Fisher; L Ambroisine; C S Foster; V Reuter; J Eastham; H Moller; M W Kattan; W Gerald; C Cooper; P Scardino; J Cuzick
Journal:  Br J Cancer       Date:  2009-03-24       Impact factor: 7.640

Review 8.  The role of postoperative radiotherapy in prostate cancer patients.

Authors:  Małgorzata Zarzycka; Ewa Ziółkowska; Tomasz Wiśniewski; Wiesława Windorbska; Agnieszka Zyromska; Zbigniew Wolski
Journal:  Contemp Oncol (Pozn)       Date:  2013-10-11

9.  Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): ability to predict cancer progression and decision-making regarding adjuvant therapy after radical prostatectomy.

Authors:  Won Ik Seo; Pil Moon Kang; Dong Il Kang; Jang Ho Yoon; Wansuk Kim; Jae Il Chung
Journal:  J Korean Med Sci       Date:  2014-09-02       Impact factor: 2.153

10.  Predicting the Risk of Metastases by PSMA-PET/CT-Evaluation of 335 Men with Treatment-Naïve Prostate Carcinoma.

Authors:  Stefan A Koerber; Johannes Boesch; Clemens Kratochwil; Ingmar Schlampp; Jonas Ristau; Erik Winter; Stefanie Zschaebitz; Luisa Hofer; Klaus Herfarth; Klaus Kopka; Tim Holland-Letz; Dirk Jaeger; Markus Hohenfellner; Uwe Haberkorn; Juergen Debus; Frederik L Giesel
Journal:  Cancers (Basel)       Date:  2021-03-25       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.